4//SEC Filing
Fishman Corey N. 4
Accession 0000950170-24-095095
CIK 0001659323other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 9:00 AM ET
Size
11.7 KB
Accession
0000950170-24-095095
Insider Transaction Report
Form 4
Fishman Corey N.
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Warrants (right to buy)
2024-08-06+82,613→ 82,613 totalExercise: $1.21From: 2024-08-09Exp: 2029-08-09→ Ordinary Shares (82,613 underlying) - Exercise/Conversion
Ordinary Shares
2024-08-06+82,613→ 137,062 total - Exercise/Conversion
Subscription Rights (right to buy)
2024-08-06−165,226→ 0 totalExercise: $0.61From: 2024-07-22Exp: 2024-08-06→ Units - Exercise/Conversion
Warrants (right to buy)
2024-08-06+82,613→ 82,613 totalExercise: $1.21From: 2024-08-09Exp: 2025-08-09→ Ordinary Shares (41,306 underlying)
Footnotes (2)
- [F1]The reported securities were purchased in the Issuer's rights offering (the "Offering") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 82,613 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance ("1-year warrants"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance ("5-year warrants").
- [F2]The Reporting Person validly exercised 165,226 subscription rights to acquire 82,613 units composed of (i) 82,613 ordinary shares, (ii) 82,613 1-year warrants and (iii) 82,613 5-year warrants.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001553594
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 9:00 AM ET
- Size
- 11.7 KB